isoxazoles has been researched along with Metabolic Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Li, X; Li, Z; Lin, X; Luo, G; Xiang, H; Xiao, M; Zhang, D | 1 |
Dai, G; Zhang, Y | 1 |
Argo, TR; Bettinger, TL; Fowler, JA | 1 |
1 review(s) available for isoxazoles and Metabolic Diseases
Article | Year |
---|---|
Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
Topics: Antipsychotic Agents; Delayed-Action Preparations; Dopamine Antagonists; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Humans; Isoxazoles; Metabolic Diseases; Paliperidone Palmitate; Pyrimidines; Randomized Controlled Trials as Topic; Schizophrenia; Secondary Prevention; Serotonin Antagonists; Tablets; Treatment Outcome | 2008 |
1 trial(s) available for isoxazoles and Metabolic Diseases
Article | Year |
---|---|
Efficacy and metabolic influence of paliperidone ER, aripiprazole and ziprasidone to patients with first-episode schizophrenia through 52 weeks follow-up in China.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Body Mass Index; China; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Female; Follow-Up Studies; Humans; Hyperglycemia; Hyperlipidemias; Isoxazoles; Male; Metabolic Diseases; Paliperidone Palmitate; Piperazines; Psychiatric Status Rating Scales; Pyrimidines; Quinolones; Schizophrenia; Thiazoles; Weight Gain; Young Adult | 2012 |
1 other study(ies) available for isoxazoles and Metabolic Diseases
Article | Year |
---|---|
Structure-guided modification of isoxazole-type FXR agonists: Identification of a potent and orally bioavailable FXR modulator.
Topics: Administration, Oral; Animals; Benzothiazoles; Drug Evaluation, Preclinical; Gene Expression Regulation; Hep G2 Cells; Humans; Isoxazoles; Lipids; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Protein Binding; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship | 2021 |